[Congressional Record (Bound Edition), Volume 158 (2012), Part 2]
[Extensions of Remarks]
[Page 1836]
[From the U.S. Government Publishing Office, www.gpo.gov]




    RECOGNIZING GARY SINDERBRAND FOR HIS SERVICE AS CHAIRMAN OF THE 
 NATIONAL BOARD OF TRUSTEES FOR THE CROHN'S AND COLITIS FOUNDATION OF 
                                AMERICA

                                 ______
                                 

                          HON. ANDER CRENSHAW

                               of florida

                    in the house of representatives

                      Wednesday, February 15, 2012

  Mr. CRENSHAW. Mr. Speaker, I rise today to recognize the dedicated 
service of Mr. Gary Sinderbrand as Chairman of the National Board of 
Trustees for the Crohn's & Colitis Foundation of America over the last 
three years.
  Joining the National Board of the Crohn's and Colitis Foundation of 
America in 2003, Mr. Sinderbrand has passionately committed to meeting 
financial goals and a rigorous research agenda while accomplishing an 
extraordinary number of professional milestones and achievements.
  Mr. Sinderbrand is a veteran of the New York investment banking 
community and currently serves as managing director with Wells Fargo in 
Manhattan, New York. He is also an active volunteer pilot for Angel 
Flight and Veteran's Airlift Command. As a parent of a child with 
Crohn's disease, Mr. Sinderbrand has shown great commitment and 
leadership to raising awareness of inflammatory bowel disease, a 
debilitating disease that currently does not have a cure to eliminate 
the suffering of over one million Americans.
  Under Mr. Sinderbrand's leadership, the Foundation has been able to 
focus on new research initiatives including the Microbiome Initiative, 
Genetics Initiative and CCFA Partners, which has helped advance the 
science and bring us one step closer to cures for Crohn's disease and 
ulcerative colitis. While we still do not have all the answers, there 
is hope. An increasing number of genes have been identified, eight in 
2007 alone. In 2011, that number grew to more than 70 genes identified, 
and with new technological advances researchers are working furiously 
to find cures.
  Together, we've made our mark on Capitol Hill with the newly formed 
Congressional Crohn's & Colitis Caucus promoting awareness and support 
for the cause. We've identified funding sources at the Department of 
Defense, National Institutes of Health and have successfully restored 
funding at the Centers for Disease Control and Prevention for the IBD 
Epidemiology Program. These are no small feats in such challenging 
times.
  Mr. Sinderbrand has set the bar high, and I'm confident he has put 
the Foundation on the right path for continued success in the future. I 
am grateful for his commitment to the National Board of Trustees for 
the Crohn's and Colitis Foundation of America at a time when the field 
of inflammatory bowel disease research is achieving such great success.

                          ____________________